|Fatigue and fatigability in neurologic illnesses: proposal for a unified taxonomy|
BM Kluger, LB Krupp, RM Enoka
Neurology 80 (4), 409-416, 2013
|Effect of high-intensity treadmill exercise on motor symptoms in patients with de novo Parkinson disease: a phase 2 randomized clinical trial|
M Schenkman, CG Moore, WM Kohrt, DA Hall, A Delitto, CL Comella, ...
JAMA neurology 75 (2), 219-226, 2018
|Palliative care and neurology: time for a paradigm shift|
I Boersma, J Miyasaki, J Kutner, B Kluger
Neurology 83 (6), 561-567, 2014
|Nonmotor manifestations of dystonia: a systematic review|
DJ Kuyper, V Parra, S Aerts, MS Okun, BM Kluger
Movement Disorders 26 (7), 1206-1217, 2011
|The therapeutic potential of cannabinoids for movement disorders|
B Kluger, P Triolo, W Jones, J Jankovic
Movement disorders 30 (3), 313-327, 2015
|Compensatory neural activity in response to cognitive fatigue|
C Wang, A Trongnetrpunya, IBH Samuel, M Ding, BM Kluger
Journal of neuroscience 36 (14), 3919-3924, 2016
|Comparison of integrated outpatient palliative care with standard care in patients with Parkinson disease and related disorders: a randomized clinical trial|
BM Kluger, J Miyasaki, M Katz, N Galifianakis, K Hall, S Pantilat, R Khan, ...
JAMA neurology 77 (5), 551-560, 2020
|Safety of transcranial magnetic stimulation in children: a systematic review of the literature|
CH Allen, BM Kluger, I Buard
Pediatric neurology 68, 3-17, 2017
|Parkinson's disease‐related fatigue: a case definition and recommendations for clinical research|
BM Kluger, K Herlofson, KL Chou, JS Lou, CG Goetz, AE Lang, ...
Movement Disorders 31 (5), 625-631, 2016
|Neuropalliative care: priorities to move the field forward|
CJ Creutzfeldt, B Kluger, AG Kelly, M Lemmon, DY Hwang, ...
Neurology 91 (5), 217-226, 2018
|Parkinson disease patients' perspectives on palliative care needs: What are they telling us?|
I Boersma, J Jones, J Carter, D Bekelman, J Miyasaki, J Kutner, B Kluger
Neurology: Clinical Practice 6 (3), 209-219, 2016
|Quadriceps muscle weakness, activation deficits, and fatigue with Parkinson disease|
J Stevens-Lapsley, BM Kluger, M Schenkman
Neurorehabilitation and Neural Repair 26 (5), 533-541, 2012
|Palliative care and Parkinson's disease: caregiver perspectives|
I Boersma, J Jones, C Coughlan, J Carter, D Bekelman, J Miyasaki, ...
Journal of palliative medicine 20 (9), 930-938, 2017
|Right and left dorsolateral pre-frontal rTMS treatment of refractory depression: a randomized, sham-controlled trial|
WJ Triggs, N Ricciuti, HE Ward, J Cheng, D Bowers, WK Goodman, ...
Psychiatry research 178 (3), 467-474, 2010
|Patient and caregiver characteristics associated with caregiver burden in Parkinson's disease: a palliative care approach|
ZA Macchi, CE Koljack, JM Miyasaki, M Katz, N Galifianakis, LP Prizer, ...
Ann Palliat Med 9 (Suppl 1), S24-33, 2020
|Fatigue in Parkinson’s disease: report from a multidisciplinary symposium|
JH Friedman, JC Beck, KL Chou, G Clark, CP Fagundes, CG Goetz, ...
NPJ Parkinson's disease 2 (1), 1-6, 2016
|Teratogenicity of antiepileptic medications|
BM Kluger, KJ Meador
Seminars in neurology 28 (03), 328-335, 2008
|Abnormalities in zinc homeostasis in young infants with cystic fibrosis|
NF Krebs, JE Westcott, TD Arnold, BM Kluger, FJ Accurso, LV Miller, ...
Pediatric research 48 (2), 256-261, 2000
|Palliative care for Parkinson’s disease: has the time come?|
JM Miyasaki, B Kluger
Current neurology and neuroscience reports 15, 1-7, 2015
|Useful field of view as a reliable screening measure of driving performance in people with Parkinson's disease: results of a pilot study|
S Classen, DP McCarthy, O Shechtman, KD Awadzi, DN Lanford, ...
Traffic injury prevention 10 (6), 593-598, 2009